Whole-exome sequencing in evaluation of patients with venous thromboembolism
- PMID: 29296762
- PMCID: PMC5728544
- DOI: 10.1182/bloodadvances.2017005249
Whole-exome sequencing in evaluation of patients with venous thromboembolism
Abstract
Genetics play a significant role in venous thromboembolism (VTE), yet current clinical laboratory-based testing identifies a known heritable thrombophilia (factor V Leiden, prothrombin gene mutation G20210A, or a deficiency of protein C, protein S, or antithrombin) in only a minority of VTE patients. We hypothesized that a substantial number of VTE patients could have lesser-known thrombophilia mutations. To test this hypothesis, we performed whole-exome sequencing (WES) in 64 patients with VTE, focusing our analysis on a novel 55-gene extended thrombophilia panel that we compiled. Our extended thrombophilia panel identified a probable disease-causing genetic variant or variant of unknown significance in 39 of 64 study patients (60.9%), compared with 6 of 237 control patients without VTE (2.5%) (P < .0001). Clinical laboratory-based thrombophilia testing identified a heritable thrombophilia in only 14 of 54 study patients (25.9%). The majority of WES variants were either associated with thrombosis based on prior reports in the literature or predicted to affect protein structure based on protein modeling performed as part of this study. Variants were found in major thrombophilia genes, various SERPIN genes, and highly conserved areas of other genes with established or potential roles in coagulation or fibrinolysis. Ten patients (15.6%) had >1 variant. Sanger sequencing performed in family members of 4 study patients with and without VTE showed generally concordant results with thrombotic history. WES and extended thrombophilia testing are promising tools for improving our understanding of VTE pathogenesis and identifying inherited thrombophilias.
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Figures
![None](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5728544/bin/advances005249absf1.gif)
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5728544/bin/advances005249f1.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5728544/bin/advances005249f2.gif)
![Figure 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5728544/bin/advances005249f3.gif)
![Figure 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5728544/bin/advances005249f4.gif)
![Figure 5.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5728544/bin/advances005249f5.gif)
![Figure 6.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5728544/bin/advances005249f6.gif)
![Figure 7.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5728544/bin/advances005249f7.gif)
Similar articles
-
Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults: A Population-Based Cohort Study.J Am Heart Assoc. 2022 Feb 15;11(4):e023018. doi: 10.1161/JAHA.121.023018. Epub 2022 Feb 3. J Am Heart Assoc. 2022. PMID: 35112923 Free PMC article.
-
Thrombophilia in Korean patients with arterial or venous thromboembolisms.Ann Surg Treat Res. 2016 Jun;90(6):340-5. doi: 10.4174/astr.2016.90.6.340. Epub 2016 May 30. Ann Surg Treat Res. 2016. PMID: 27274510 Free PMC article.
-
Role of the geneticist in testing and counseling for inherited thrombophilia.Genet Med. 2003 May-Jun;5(3):133-43. doi: 10.1097/01.GIM.0000067987.77803.D0. Genet Med. 2003. PMID: 12792420 Review.
-
Hereditary thrombophilia and venous thromboembolism.Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1369-73. doi: 10.1164/ajrccm.158.5.9712022. Am J Respir Crit Care Med. 1998. PMID: 9817680 Review.
-
Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.Haematologica. 2000 Dec;85(12):1271-6. Haematologica. 2000. PMID: 11114134
Cited by
-
Whole-Exome Sequencing in a Family with an Unexplained Tendency for Venous Thromboembolism: Multicomponent Prediction of Low-Frequency Variant Deleteriousness and of Individual Protein Interaction.Int J Mol Sci. 2023 Sep 7;24(18):13809. doi: 10.3390/ijms241813809. Int J Mol Sci. 2023. PMID: 37762110 Free PMC article.
-
Argatroban Resistance and Successful Adjunctive Anticoagulation for Cerebral Venous Sinus Thrombosis With SERPINC1 Mutation: A Case Report.Neurol Clin Pract. 2023 Apr;13(2):e200122. doi: 10.1212/CPJ.0000000000200122. Epub 2023 Mar 1. Neurol Clin Pract. 2023. PMID: 37064580 Free PMC article.
-
Venous thromboembolism with renal infarct due to paradoxical embolism.BMJ Case Rep. 2023 Mar 28;16(3):e252322. doi: 10.1136/bcr-2022-252322. BMJ Case Rep. 2023. PMID: 36977511
-
Whole Genome Analysis of Venous Thromboembolism: the Trans-Omics for Precision Medicine Program.Circ Genom Precis Med. 2023 Apr;16(2):e003532. doi: 10.1161/CIRCGEN.121.003532. Epub 2023 Mar 24. Circ Genom Precis Med. 2023. PMID: 36960714 Free PMC article.
-
[Research progress of Molecular diagnostic technique in Venous Thromboembolism].Zhonghua Xue Ye Xue Za Zhi. 2022 Nov 14;43(11):964-968. doi: 10.3760/cma.j.issn.0253-2727.2022.11.015. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 36709191 Free PMC article. Chinese. No abstract available.
References
-
- Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(suppl 4):S495-S501. - PubMed
-
- Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353(9159):1167-1173. - PubMed
-
- van Sluis GL, Söhne M, El Kheir DY, Tanck MW, Gerdes VE, Büller HR. Family history and inherited thrombophilia. J Thromb Haemost. 2006;4(10):2182-2187. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources